BackImmutep Limited Overview

Immutep Limited Total Revenue

Latest total revenue for IMMP: $22M, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$10.62M
↑ 460.33% YoY

As of Jun 2026

Annual Revenue (TTM)

$21.69M
↑ 286.27% YoY

Trailing 12 months ending Jun 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Immutep Limited (IMMP) FAQ

The latest total revenue for IMMP is $22M as of June 2026. That compares with $5.6M in the prior-year period — up 286.3% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Immutep Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMMP's total revenue moved from $5.6M to $22M — a 286.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immutep Limited's operating scale or balance-sheet position.

Against Healthcare companies, IMMP currently prints $22M for total revenue, while the sector average sits near $110B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Immutep Limited's growth, margins, and balance sheet.

A total revenue figure of $22M for IMMP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting IMMP's total revenue ($22M), review year-over-year change from $5.6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.